Prospects in radionuclide imaging of prostate cancer

Phase II trial of 177Lutetium radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu- J591) in patients (pts) with metastatic castrate-resistant prostate cancer (metCRPC)

(2017) S. T. Tagawa et al.   JOURNAL OF CLINICAL ONCOLOGY

Estimates of cancer incidence and mortality in Europe in 2008

(2010) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

Early response assessment in prostate carcinoma by 18F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models

(2010) Nobuyuki Oyama et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues

(2010) Rogier P. J. Schroeder et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Targeting Prostate Cancer Cells In Vivo Using a Rapidly Internalizing Novel Human Single-Chain Antibody Fragment

(2010) J. He et al.   JOURNAL OF NUCLEAR MEDICINE

Radionuclide and hybrid imaging of recurrent prostate cancer

(2010) Ambros J Beer et al.   LANCET ONCOLOGY

Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7–14)NH2], in a prostate tumor xenografted mouse model

(2010) Stephanie R. Lane et al.   NUCLEAR MEDICINE AND BIOLOGY

High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMA

(2010) Karen Alt et al.   PROSTATE

PET/CT Imaging and Radioimmunotherapy of Prostate Cancer

(2010) Kirsten Bouchelouche et al.   SEMINARS IN NUCLEAR MEDICINE

Technological Advances in Radiation Therapy for Prostate Cancer

(2010) Mehee Choi et al.   Current Urology Reports

Imaging Localized Prostate Cancer: Current Approaches and New Developments

(2009) Baris Turkbey et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Positron emission tomography imaging of prostate cancer

(2009) Hao Hong et al.   AMINO ACIDS

Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells

(2009) Amanda L. Martin et al.   JOURNAL OF NANOPARTICLE RESEARCH

2-18F-Fluoropropionic Acid as a PET Imaging Agent for Prostate Cancer

(2009) N. Pillarsetty et al.   JOURNAL OF NUCLEAR MEDICINE

Small-Animal PET of Tumors with 64Cu-Labeled RGD-Bombesin Heterodimer

(2009) Z. Liu et al.   JOURNAL OF NUCLEAR MEDICINE

Prostate-Specific Membrane Antigen Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing Ligand

(2009) Sumith A. Kularatne et al.   MOLECULAR PHARMACEUTICS

Imaging techniques for prostate cancer: implications for focal therapy

(2009) Baris Turkbey et al.   Nature Reviews Urology

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE

Humanized Radioiodinated Minibody For Imaging of Prostate Stem Cell Antigen-Expressing Tumors

(2008) J. V. Leyton et al.   CLINICAL CANCER RESEARCH

N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-L-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer

(2008) R. C. Mease et al.   CLINICAL CANCER RESEARCH

Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET–CT: a comparative study

(2008) Mohsen Beheshti et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology

(2008) Thomas C. Kwee et al.   EUROPEAN RADIOLOGY

Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer

(2008) A. B. Apolo et al.   JOURNAL OF NUCLEAR MEDICINE

18F-Labeled BBN-RGD Heterodimer for Prostate Cancer Imaging

(2008) Z.-B. Li et al.   JOURNAL OF NUCLEAR MEDICINE

MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study

(2008) Roel AM Heesakkers et al.   LANCET ONCOLOGY